Thus far, there is a lack of clinical research in the United States demonstrating the safety and efficacy of injection lipolysis treatments. The first FDA-approved clinical study is being conducted to determine the effectiveness of this technology.
Injection lipolysis - often referred to as lipodissolve or mesotherapy - involves injecting a mixture of chemicals, generally consisting of a combination of phosphatidylcholine and sodium deoxycholate, into the skin and/or subcutaneous fatty tissue in order to dissolve fat cells. Some treatments also contain vitamins in the injection mixture.
Neither the injection mixture nor the method of treatment is standardized, and the procedures are not approved by the FDA for any purpose.
There are still many unknowns about these procedures. What happens to the fat cells once they are treated, how much fat is removed, and how the treatment affects other parts of the anatomy?
Some known side effects that may occur are allergic reaction, skin ulceration, scarring and infection.
Many of the topics discussed in this section are procedures or technologies that are relatively new or currently under clinical investigation and may require further scientific study to determine efficacy and success rate.
These topics are presented for research and education purposes only. The ASPS does not endorse the procedures or technologies in this section.
Physicians using such procedures or technologies are advised to make individual treatment decisions according to their own medical judgment in light of each patient's individual circumstance.
Further, any reporting or publication of the information presented must be done responsibly with full disclosure of its unproven nature.